Core Scientific (NASDAQ:CORZ) Shares Down 7.4% After Insider Selling

Core Scientific, Inc. (NASDAQ:CORZ)’s stock price was down 7.4% during mid-day trading on Wednesday following insider selling activity. The company traded as low as $14.46 and last traded at $14.2860. 2,120,247 shares changed hands during mid-day trading, a decline of 83% from the average daily volume of 12,457,098 shares. The stock had previously closed at $15.43.

Specifically, insider Todd DuChene sold 10,000 shares of the firm’s stock in a transaction that occurred on Monday, October 12th. The shares were sold at an average price of $15.12, for a total transaction of $151,200.00. Following the completion of the sale, the insider owned 1,159,668 shares of the company’s stock, valued at $17,534,180.16. This trade represents a 0.85% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on CORZ shares. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Core Scientific in a research report on Thursday. UBS Group reissued a “market outperform” rating on shares of Core Scientific in a report on Wednesday. Needham & Company LLC lifted their target price on Core Scientific from $29.00 to $35.00 and gave the stock a “buy” rating in a report on Wednesday, July 29th. Wells Fargo & Company started coverage on Core Scientific in a research note on Thursday, September 17th. They issued an “overweight” rating and a $28.00 price target for the company. Finally, Wolfe Research reaffirmed a “buy” rating on shares of Core Scientific in a report on Wednesday, July 29th. Two equities research analysts have rated the stock with a Strong Buy rating, eighteen have given a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $31.36.

Key Headlines Impacting Core Scientific

Here are the key news stories impacting Core Scientific this week:

• Positive Sentiment: Analyst support strengthened: Canaccord Genuity reaffirmed a “Buy” rating with a $36 price target, while BTIG Research maintained its “Buy” rating with a $38 target. Cantor Fitzgerald also reaffirmed an “Overweight” rating and set a $39 target. These targets imply substantial upside from recent trading levels. Canaccord Genuity Core Scientific rating
• Positive Sentiment: Needham maintained its $35 target: The firm reiterated its bullish valuation even as it noted credit pressure facing Core Scientific’s tenant, CoreWeave. Continued analyst confidence supports the investment case for CORZ’s data-center and AI infrastructure expansion. Needham reiterates Core Scientific price target
• Neutral Sentiment: Upcoming earnings event: Core Scientific will release third-quarter fiscal 2026 results before the market opens on November 5 and hold a conference call at 8:30 a.m. Eastern time. Investors will look for updates on revenue, profitability, customer demand and AI data-center capacity. Core Scientific third-quarter 2026 earnings announcement
• Negative Sentiment: Insider sale adds a modest cautionary signal: Director Todd DuChene sold 10,000 shares for approximately $151,200, reducing his direct ownership by 0.85%. He still retains a substantial position, so the transaction may have limited significance, but insider selling can weigh on sentiment.
• Negative Sentiment: Tenant credit risk remains a concern: Needham’s commentary indicates that financial pressure at CoreWeave could create uncertainty for Core Scientific because of the tenant relationship, potentially affecting contract execution or investor confidence despite the maintained price target.

Core Scientific Stock Up 7.0%

The firm’s 50 day simple moving average is $17.45 and its 200 day simple moving average is $21.05. The company has a market capitalization of $4.64 billion, a PE ratio of -3.27 and a beta of 5.49.

Core Scientific (NASDAQ:CORZ) last announced its earnings results on Tuesday, July 28th. The company reported ($3.32) earnings per share for the quarter, missing the consensus estimate of ($0.06) by ($3.26). The firm had revenue of $164.20 million for the quarter, compared to analyst estimates of $144.83 million. As a group, sell-side analysts predict that Core Scientific, Inc. will post -1.36 EPS for the current fiscal year.

Hedge Funds Weigh In On Core Scientific

Large investors have recently made changes to their positions in the company. State of Alaska Department of Revenue lifted its stake in Core Scientific by 36.7% in the third quarter. State of Alaska Department of Revenue now owns 17,493 shares of the company’s stock worth $279,000 after purchasing an additional 4,701 shares during the last quarter. Reliant Investment Management LLC purchased a new position in shares of Core Scientific during the third quarter valued at approximately $336,000. CoreCap Advisors LLC boosted its position in shares of Core Scientific by 205.6% during the third quarter. CoreCap Advisors LLC now owns 4,355 shares of the company’s stock valued at $70,000 after buying an additional 2,930 shares during the period. Moody National Bank Trust Division grew its stake in shares of Core Scientific by 83.0% during the third quarter. Moody National Bank Trust Division now owns 114,699 shares of the company’s stock valued at $1,833,000 after buying an additional 52,039 shares during the last quarter. Finally, Byrne Asset Management LLC bought a new position in shares of Core Scientific during the third quarter valued at approximately $225,000.

About Core Scientific

Core Scientific, Inc is a digital infrastructure company that develops and operates data centers in the United States. Its business has historically centered on cryptocurrency mining, particularly the processing of transactions on the Bitcoin network, while also providing hosting and infrastructure services to other mining and technology customers.

The company is expanding its data center capabilities to support high-performance computing and artificial intelligence workloads. Its services include data center operations, power and equipment management, hosting, and related infrastructure support for customers that require substantial computing capacity.

Core Scientific was founded in 2017 and became a publicly traded company through a business combination in 2022.